A UK patient has become the first with multiple sclerosis (MS) to receive cutting-edge CAR T-cell therapy, as scientists test whether the one-time treatment can halt disease progression.
MS Australia is a national not-for-profit organisation dedicated to improving the lives of those affected by multiple sclerosis. Its remit includes supporting research for...
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders